Supplementary Material to RepurposeDB

<div>Systematic analyses of drugs, diseases and drug targets in RepurpodeDB</div><div>Supplementary Data files in Excel format </div><div><br></div><div>RepurposeDB_BinChe.xlsx</div><div>RepurposeDB_CGEA.xlsx</div><div>RepurposeDB_ChemicalProperties.xlsx</div><div>RepurposeDB_CPDB.xlsx</div><div>RepurposeDB_DAVID.xlsx</div><div>RepurposeDB_DiseaseSimilarity.xlsx</div><div>RepurposeDB_Drug_Food_Target_Networks.xlsx</div><div>RepurposeDB_EHR_SGA.xlsx</div><div>RepurposeDB_Enrichr.xlsx</div><div>RepurposeDB_EvidenceTypes.xlsx</div><div>RepurposeDB_PanOntology_Mapping.xlsx</div><div>RepurposeDB_Pharmacoeconomics.xlsx</div><div>RepurposeDB_PubMed_Articles.xlsx</div><div>RepurposeDB_SFN_EFN_NA.xlsx</div><div><br></div><div>Compiled on Aug 16 2016 </div><div>Compiled by Khader Shameer, Benjamin Glicksberg, Marcus A Badgeley, Tim O’ Connor & Max S Tomlinson</div><div><br></div><div>Contact us at [email protected] | [email protected] </div><div><br></div><div>Dataset accompnying the following manuscript: </div><div>Systematic analyses of 253 drugs and 1125 disease indications in RepurposeDB reveal chemical, biological and epidemiological factors influencing drug repositioning </div><div><br></div><div>Khader Shameer^1, Benjamin S. Glicksberg¹, Rachel Hodos¹, Marcus A. Badgeley¹, Kipp W Johnson¹, Ben Readhead¹ , Max S. Tomlinson¹, Timothy O’Connor^1,2, Riccardo Miotto¹, Brian A. Kidd¹, Rong Chen¹, Avi Ma’ayan³ and Joel T. Dudley^1,2*  </div><div><br></div><div>¹ Department of Genetics and Genomic Sciences, Harris Center for Precision Wellness, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, New York, USA. </div><div><br></div><div>² Boston College, Morrissey College of Arts and Sciences, Chestnut Hill, MA</div><div><br></div><div>³ Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, Systems Biology Center New York (SBCNY), Mount Sinai Health System, New York, New York, USA. </div><div><br></div><div>⁴ Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, New York, USA.</div><div><br></div><div><b>^*Corresponding author:</b> [email protected] </div><div><br></div

Supplemental Data: A Network-Biology Informed Computational Drug Repositioning Strategy to Target Disease Risk Trajectories and Comorbidities of Peripheral Arterial Disease.

<div><div>Supplemental Data: </div><div>A Network-Biology Informed Computational Drug Repositioning Strategy to Target Disease Risk Trajectories and Comorbidities of Peripheral Arterial Disease. </div></div><div><br></div